Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.
for
Health Options, Strategic Care Planning
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06722846
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
for
Narcolepsy Type 1
Location: Sugar Land TX, Austin TX, San Antonio TX, Cullman AL,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07455383
Phase 3, Recruiting
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
for
Breast Cancer, Ovarian Cancer, Endometrial Cancer,
Location: Houston TX, San Antonio TX, Pittsburgh PA, Fairfax VA,
Sponsor: Regor Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT07524322
Phase 1, Recruiting
Bowel Continence Across the Lifespan in People With Spina Bifida
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Houston TX, Irving TX, Nashville TN, Tampa FL,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05954312
Phase 1, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
for
Pemphigus Vulgaris
Location: Houston TX, Dallas TX, Iowa City IA, Chicago IL,
Sponsor: Cabaletta Bio
Sex: All
Age: 18+
Code: NCT04422912
Phase 1, Phase 2, Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease